Facilitating Biomarker Development: Strategies for Scientific Communication, Pathway Prioritization, Data-Sharing, and Stakeholder Collaboration

June 30, 2016

In this white paper, a working group of experts address key challenges in biomarker development and validation, including inconsistent terminology; confusion surrounding the various regulatory pathways for biomarker acceptance; the need for data standards and improved collaboration in data sharing; and the lack of coordination and prioritization of limited public and private resources. The paper follows a 2015 public conference held on this topic.